“The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach,” said Emma Walmsley, GSK CEO

World leading pharma company refreshes strategy and moves forward with digital health agenda

[London, UK] GlaxoSmithKline (GSK) has appointed former Walmart Chief Information Officer Karenann Terrell as the company’s first Chief Digital and Technology Officer.

Terrell is set to start her tenure at GSK this September, becoming a member of its corporate executive team.

She will be tasked with developing the pharma giant’s digital, data and analytics strategy and introducing cutting edge technologies to steer innovation in the field.

Emma Walmsley, GSK CEO, said in regard to Terrell’s appointment:

“The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach.

“As a member of the Executive Team, Karenann will have the scope to think radically about how we can exploit the latest opportunities and ultimately improve our business performance.”

In its second quarter results for 2017, GSK named strengthening innovation as one of its ‘new business priorities to 2020’.

The change in strategy is marked by Walmsley’s appointment as the company’s CEO in April this year. Walmsley initially joined GSK in 2010 after having spent 17 years at L’Oreal, holding a number of different marketing and management roles. 

Related News

Getting pharmacists electronically connected to patient discharge will radically improve treatment

eHealth Week, European Commission

Never underestimate the phenotype, says UK CCIO

Genomics England extends access to datasets for researchers

More than 500 researchers will be able to access the 100,000 Genomes Project dataset